Database Proof Substratum: Substratum of Proof LGBTQs Are Mentally Ill: NIH launches HIV prevention trial of long-acting injectable medication in women

Gendrome Editors' Note: The article below provides the raw material for a proof and is not the proof itself. In addition, the raw material may contain one or more false statements and/or some offensive, outside content.

(NIH/National Institute of Allergy and Infectious Diseases) The first large-scale clinical trial of a long-acting injectable medication for HIV prevention in sexually active women has begun. The study in southern and eastern Africa will examine whether a long-acting form of the investigational anti-HIV drug cabotegravir injected once every eight weeks can safely protect women at risk for HIV infection. NIH is sponsoring the trial, and the NIH-funded HIV Prevention Trials Network (HPTN) is conduc...